美康生物品牌怎么样 申请店铺

我要投票 美康生物在医疗器械行业中的票数:559 更新时间:2025-08-12
美康生物是哪个国家的品牌?「美康生物」是美康盛德旗舰店旗下著名品牌。该品牌发源于浙江省宁波市,由创始人邹 * 德在2003年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力美康生物品牌出海!将品牌入驻外推网,定制美康生物品牌推广信息,可以显著提高美康生物产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

美康生物怎么样

美康生物是一家专业从事医学诊断产品研发、生产、销售及服务的企业。公司创立于2003年,矗立于宁波,2015年在深交所创业板成功上市,股票代码300439。

美康生物主要产业为体外诊断试剂、仪器及独立第三方医学诊断服务。公司秉承以人为本、科技创新的宗旨来建立自己的特色,严格按照GMP标准组织生产。目前已取得140余项体外诊断试剂产品注册证书,是我国生化诊断试剂领域品种齐全的供应商之一;并取得9项诊断仪器产品注册证书,是行业内同时能够提供诊断试剂和诊断仪器的少数供应商之一。

公司打造以提供区域性医学检验服务为核心的第三方医学检验中心。拥有自主研发的区域LIS系统、现代化消毒中心、冷链物流系统、美康云平台等多项配套系统。大力助推分级诊疗的落地,加快各级医疗机构信息化改革的步伐,提升医院的管理水平、服务质量及综合竞争力。

美康生物成为医学检验集约化系统供应商,为客户提供实验室整体解决方案。公司将持续推出高科技含量产品,深入提供服务,为客户创造价值,为中国体外诊断事业的发展,为中国人民的健康做出更大贡献!


Meikang biology is a professional enterprise engaged in the research and development, production, sales and service of medical diagnosis products. Founded in 2003 and standing in Ningbo, the company was successfully listed on the growth enterprise market of Shenzhen Stock Exchange in 2015, with the stock code of 300439. Our main industries are in vitro diagnostic reagents, instruments and independent third-party medical diagnostic services. The company adheres to the tenet of people-oriented and scientific and technological innovation to establish its own characteristics and organize production in strict accordance with GMP standards. At present, it has obtained more than 140 in vitro diagnostic reagent product registration certificates, and is one of the suppliers with complete varieties in the field of biochemical diagnostic reagents in China. It has also obtained 9 registration certificates of diagnostic instrument products, which is one of the few suppliers in the industry that can provide diagnostic reagents and diagnostic instruments at the same time. The company has built a third-party medical testing center with the core of providing regional medical testing services. It has self-developed regional LIS system, modern disinfection center, cold chain logistics system, Meikang cloud platform and other supporting systems. Vigorously promote the implementation of hierarchical diagnosis and treatment, accelerate the pace of information-based reform of medical institutions at all levels, and improve the management level, service quality and comprehensive competitiveness of hospitals. Meikang biology has become a supplier of intensive medical testing system, providing customers with overall laboratory solutions. The company will continue to launch high-tech products, provide in-depth services, create value for customers, and make greater contributions to the development of China's in vitro diagnostic industry and the health of the Chinese people!

本文链接: https://brand.waitui.com/eed8e50ac.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

东风集团股份:1-7月累计汽车销量同比下降约8.9%

36氪获悉,东风集团股份发布公告,1-7月累计汽车销量为978462辆,同比下降约8.9%。其中,新能源汽车销量为249571辆,同比增长约35.5%。母公司东风汽车集团有限公司1-7月累计汽车销量为1260406辆,同比下降约10.8%。

19分钟前

奇德新材:实控人拟减持公司不超2%股份

36氪获悉,奇德新材发布公告,公司控股股东、实控人饶德生计划以集中竞价、大宗交易方式,合计减持公司股份不超过167.91万股,即不超过公司扣除回购专户股份后总股本的2%。

19分钟前

美股大型科技股盘前多数上涨,特斯拉涨超2%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,英特尔、特斯拉涨超2%,亚马逊涨0.39%,Meta涨0.19%,微软涨0.18%,奈飞涨0.11%;苹果跌0.52%,英伟达跌0.4%,谷歌跌0.23%。

19分钟前

热门中概股美股盘前多数上涨,小鹏汽车涨超4%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,小鹏汽车涨超4%,哔哩哔哩、蔚来涨超2%,拼多多涨0.29%,百度涨0.21%;理想汽车跌超2%,京东跌0.76%,阿里巴巴跌0,02%。

19分钟前

英伟达与AMD同意向美政府上缴15%的收入,外交部回应

8月11日,外交部发言人林剑答记者问。路透社记者提问,据报道,英伟达公司与超威半导体公司已同意向美国政府上缴在华芯片销售收入的15%,以换取对华出口许可证。中方对此有何评论?(英国广播公司亦问及)林剑表示,在美输华芯片问题上,中方已经多次表明了立场。(北京日报)

19分钟前

本页详细列出关于美康生物的品牌信息,含品牌所属公司介绍,美康生物所处行业的品牌地位及优势。
咨询